Home
NUWE
NUWE News

Latest Nuwellis Inc. (NUWE) News on November 18, 2024

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire

7 days ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

GlobeNewswire

13 days ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System

GuruFocus.com

14 days ago

Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

GlobeNewswire

14 days ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

GlobeNewswire

17 days ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

GlobeNewswire

18 days ago

Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

GlobeNewswire

a month ago

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

GlobeNewswire

2 months ago

Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

GlobeNewswire

3 months ago

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

3 months ago

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions

GlobeNewswire

3 months ago

Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

GlobeNewswire

4 months ago

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

4 months ago

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

GlobeNewswire

4 months ago

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

GlobeNewswire

4 months ago

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

GlobeNewswire

4 months ago

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

GlobeNewswire

4 months ago

New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

Nuwellis Announces Reverse Stock Split

GlobeNewswire

5 months ago

Nuwellis Announces Reverse Stock Split

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

GlobeNewswire

5 months ago

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

Simply Wall St.

5 months ago

With 58% ownership, Berliner Effektengesellschaft AG (FRA:BFV) insiders have a lot at stake

Better AI Stock: Palantir vs. Snowflake

Motley Fool

5 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

5 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

Simply Wall St.

5 months ago

Why We Like The Returns At CTS Eventim KGaA (ETR:EVD)

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

5 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

5 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

5 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

5 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

GlobeNewswire

5 months ago

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

GlobeNewswire

6 months ago

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

GlobeNewswire

6 months ago

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

GlobeNewswire

7 months ago

Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

Nuwellis Announces Closing of $2.7 Million Public Offering

GlobeNewswire

7 months ago

Nuwellis Announces Closing of $2.7 Million Public Offering

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

GlobeNewswire

7 months ago

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

Nuwellis Announces Pricing of $2.7 Million Public Offering

GlobeNewswire

7 months ago

Nuwellis Announces Pricing of $2.7 Million Public Offering

Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

GlobeNewswire

7 months ago

Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

Nuwellis Full Year 2023 Earnings: EPS Beats Expectations

Simply Wall St.

8 months ago

Nuwellis Full Year 2023 Earnings: EPS Beats Expectations

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

GlobeNewswire

8 months ago

Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

8 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

GlobeNewswire

9 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

GlobeNewswire

9 months ago

Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

GlobeNewswire

9 months ago

Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

GlobeNewswire

9 months ago

New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

10 months ago

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Nortech Systems Expands Fiber Optic Capabilities with Innovative Expanded Beam XtremeTM Technology

Business Wire

10 months ago

Nortech Systems Expands Fiber Optic Capabilities with Innovative Expanded Beam XtremeTM Technology

Air Industries Group Receives Two Strategically Important New Contracts from New Customers

Business Wire

10 months ago

Air Industries Group Receives Two Strategically Important New Contracts from New Customers

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

ACCESSWIRE

10 months ago

Fury Intercepts 31.77 g/t gold and 8.07 g/t Tellurium over 3.5 metres at the Hinge Target

Energous Announces Change of Chief Financial Officer

Business Wire

10 months ago

Energous Announces Change of Chief Financial Officer

CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management

GlobeNewswire

10 months ago

CPI Aerostructures Appoints Ross Johnson to Leadership Team as Vice President, Program Management

Are Consumer Staples Stocks Lagging Coca-Cola HBC (CCHGY) This Year?

Zacks

10 months ago

Are Consumer Staples Stocks Lagging Coca-Cola HBC (CCHGY) This Year?

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

GlobeNewswire

10 months ago

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology

GlobeNewswire

10 months ago

Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology

Air Industries Group Subsidiary Sterling Engineering Corporation Receives $3.2M in New Contracts

Business Wire

10 months ago

Air Industries Group Subsidiary Sterling Engineering Corporation Receives $3.2M in New Contracts

Reasons Why A. O. Smith (AOS) Should be in Your Portfolio Now

Zacks

a year ago

Reasons Why A. O. Smith (AOS) Should be in Your Portfolio Now

Trust Stamp has partnered with Scurid to deliver highly secure, AI-powered in-field authentication for seamless human-machine interaction

GlobeNewswire

a year ago

Trust Stamp has partnered with Scurid to deliver highly secure, AI-powered in-field authentication for seamless human-machine interaction

Northern Dynasty Closes US$15 Million Convertible Notes Offering and CAD$3.4 Million Private Placement

ACCESSWIRE

a year ago

Northern Dynasty Closes US$15 Million Convertible Notes Offering and CAD$3.4 Million Private Placement

BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program

GlobeNewswire

a year ago

BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

GlobeNewswire

a year ago

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

Momentus Mission Update

Business Wire

a year ago

Momentus Mission Update

Express (EXPR) Q3 2023 Earnings Call Transcript

Motley Fool

a year ago

Express (EXPR) Q3 2023 Earnings Call Transcript

Sangoma to Showcase Innovations at Benchmark Discovery One-on-One Conference in New York

Business Wire

a year ago

Sangoma to Showcase Innovations at Benchmark Discovery One-on-One Conference in New York

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

GlobeNewswire

a year ago

New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 REITs With Recent Insider Buying

Benzinga

a year ago

5 REITs With Recent Insider Buying

Phoenix Wins Contract Under Florida Sheriffs Association Cooperative Purchasing Program for Electric School Buses

ACCESSWIRE

a year ago

Phoenix Wins Contract Under Florida Sheriffs Association Cooperative Purchasing Program for Electric School Buses

Thomson Reuters StreetEvents

a year ago

Q3 2023 Symbotic Inc Earnings Call

Symbotic Inc. (NASDAQ:SYM) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Symbotic Inc. (NASDAQ:SYM) Q4 2023 Earnings Call Transcript

Professional Diversity Network Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.11 loss in 3Q 2022)

Simply Wall St.

a year ago

Professional Diversity Network Third Quarter 2023 Earnings: US$0.12 loss per share (vs US$0.11 loss in 3Q 2022)

Favourable Signals For OLB Group: Numerous Insiders Acquired Stock

Simply Wall St.

a year ago

Favourable Signals For OLB Group: Numerous Insiders Acquired Stock

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

OLB Group to Conduct Second Quarter Earnings Call November 15

ACCESSWIRE

a year ago

OLB Group to Conduct Second Quarter Earnings Call November 15

The Dixie Group, Inc. (NASDAQ:DXYN) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

The Dixie Group, Inc. (NASDAQ:DXYN) Q3 2023 Earnings Call Transcript

Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Allied Gaming & Entertainment Inc. (NASDAQ:AGAE) Q3 2023 Earnings Call Transcript

Origin Materials, Inc. Reports Operating and Financial Results for Third Quarter 2023

Business Wire

a year ago

Origin Materials, Inc. Reports Operating and Financial Results for Third Quarter 2023

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

GlobeNewswire

a year ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Nuwellis, Inc. Announces Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Nuwellis, Inc. Announces Third Quarter 2023 Financial Results

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

GlobeNewswire

a year ago

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

Steven J. Pully Appointed to Enzo Biochem’s Board of Directors

GlobeNewswire

a year ago

Steven J. Pully Appointed to Enzo Biochem’s Board of Directors

Share on Social Networks: